Doctors call for cigarette-style warning label on GLP-1 drugs like Ozempic due to this ‘very dangerous’ risk
There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in record numbers, providers are warning of a troubling ripple effect: patients sliding back into restrictive eating disorders — and others developing them for the first time. “I think there should be a button that you have to … Read more